Diabetic foot ulcers remain difficult to heal and nutritional supplementation may be an important complementary therapeutic measure. However, we need to clarify many issues before such supplementation is more widely used. Indeed, improvements are needed in the following areas: evaluation of nutritional inadequacy, completion of randomized controlled trials, understanding of patient and ulcer characteristics that favor response to nutritional supplementation, optimal duration of supplementation therapy, and evaluation of patient adherence. The challenge is now to acquire more knowledge in the aforementioned areas.
Guest Editorial
The development of a foot ulceration (DFU) is one of the most common and challenging complications of diabetes, affecting up to 25% to 35% of patients over their lifetime. 1 A recent appraisal of the health care expenditure on the management of DFU estimated that >£1 billion was spent in England during 2015, without accounting for indirect costs due to loss of productivity. Despite advances in wound care delivery and multidisciplinary therapeutic strategies, a significant proportion of DFUs fail to heal within a reasonable time frame. 2, 3 Failure to heal is associated with significant morbidity, including recurrent infections and hospitalisation. 4 Worryingly, it also carries a high risk of lower extremity amputation. 5 Wound healing is a complex, dynamic process comprising of 4 overlapping phases: hemostasis, inflammation, proliferation, and tissue remodeling. 6 Any interruption in the sequence of this precisely programmed activity has the potential to delay healing, allowing the wound to enter a chronic, nonhealing stage. 6 Local factors, such as hypoxia and infections, alongside systemic factors, notably age, stressor responses, diabetes, and nutrition exert a role in wound healing. 6 Indeed, in critical and post-operative care, providing early nutritional support, usually parenteral, is now considered a routine measure. 7 The diabetic wound is typically accompanied by hypoxia, even in the absence of genuine vascular disease, 8 while hyperglycemia may amplify the inflammatory response via oxidative stress. 9, 10 Neuropathy contributes to immune paresis and may downregulate cell proliferation. 6, 10 Furthermore, neuropathy and loss of pain sensation will drive inordinate pressure loading through the insensate ulcerated foot, thereby causing further impairment of healing by cycling the ulcer through tissue breakdown and repair. 11 Current strategies to improve DFU healing rates continue to be unsatisfactory. 12, 13 Rather frustratingly, in the largest audit of its kind of real-world outcomes, up to 50% of all DFU remained unhealed at 6 months. 14 While there are many reasons for this finding, such as delays in referral in access to appropriate multidisciplinary care, 3 there is increasing recognition that significant nutritional challenges exist in individuals with DFU, which may also hinder healing. [15] [16] [17] These include inadequate intake of both macronutrients (most recognized and studied) and micronutrients. In one retrospective assessment of DFU prognosis, moderate or severe malnutrition, as measured using the Subjective Global Assessment (SGA) tool, was present in 62% of participants. 17 Nutritional status was independently correlated with severity of infection (r = 0.64, P < .001) and increased risk of poor outcome (odds ratio 10.6, P < .001). Furthermore, patients' nutritional state worsened as the severity of the DFUs according to Wagner score increased. 17 Nutritional status is also independently associated with poor prognosis after vascular interventions, 18 and it even predicts amputation. 19, 20 In this issue of the journal, Kulprachakarn et al 21 provide a qualitative review of the role of oral micronutrients and natural compounds in the management of DFU. In this, the supportive evidence available for vitamins such as D, E, C, and A, as well as minerals and trace elements zinc, magnesium, and iron amongst others is explored. 21 They conclude that micronutrients can be vital to tissue repair and provide encouraging in vitro as well as in vivo clinical evidence. However, they also note that high quality prospective studies with outcome data, DFU healing in particular, are lacking. 21 Therein lies the challenge. While it is not a criticism of the review itself, there are major methodology challenges in the studies found and reviewed. Many of the studies included in the review are not randomized and seem to suffer from inherent bias in recruitment and analysis. [22] [23] [24] Indeed, very few studies report on baseline levels of the micronutrients evaluated, and even fewer provided clear longitudinal data. Important statistical analyses, such as adjusting for confounding variables, linear and logistic regression analysis to detect an independent association would also be welcome. Furthermore, a significant proportion of the research reviewed was in vitro work or based on animal models. Additionally, certain data seem to be extrapolated to DFU, while in reality they pertain to patients with pressure or leg ulcers, a subgroup of whom have diabetes. Adding to the debate, micronutrient supplementation closely mirrors cultural preferences, and some of the work evaluated by Kulprachakarn et al. 21 reflects the trend. Finally, the funding sources in many of the papers reviewed is unclear. Overall, the strength of clinical evidence provided, if assessed against the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE), will not be strong.
Taken together, these findings highlight the challenges that need consideration in the enquiry into DFU malnutrition, while interpreting current evidence and formulating future research. First, there is no internationally agreed standardized definition of malnutrition, neither for proteinenergy malnutrition nor for micronutrient deficiency, in the context of chronic wounds or in DFU. Although there are diagnostic tools, such as Mini Nutritional Assessment (MNA) and SGA, they are weighted toward detecting macronutrient rather micronutrient deficiency.
Second, there is a paucity of high-quality randomized controlled trials (RCTs) to evaluate the benefits of nutritional supplementation in DFU. A recent excellent quantitative systematic review by Ye and Mani 25 published in 2016, found only 3 RCTs and reported a nonsignificant trend for nutritional supplementation in the treatment of DFU (relative risk 1.17, 95% confidence interval 0.93-1.47). Two of the studies were on protein-based supplementation, while the third used a herbal supplement. They did not identify any RCTs on micronutrient supplementation in DFU. The recently published RCT by Razzaghi et al 26 in vitamin D-deficient individuals found that the group randomized to receive vitamin D supplementation had smaller DFU length, width and depth at 12 weeks, but it did not report that any of these patients had actually healed. Moreover, given that patients with Wagner-Meggitt grade 3 (indicating DFU with abscess or osteomyelitis) were included, it is unclear what medical or surgical therapies were offered. 26 Third, there is an overall substantial heterogeneity in the type of patients included in published studies and in the medical/surgical management involved. 15, 16, 23, 24 Therefore, their results may not be generalizable to all patients with DFU. Even higher quality studies have limited inclusion criteria to simple noninfected neuropathic ulcers (University of Texas 1A category), 15, 16 but on many occasions, the ulcer grade and clinical phenotype of patients is rather unclear. Epidemiologic studies have suggested that such neuropathic DFUs tend to heal with early input, good wound care and appropriate offloading. 25, 26 Conversely, patients with infection, ischemia, renal failure, and osteomyelitis are more challenging, 25, 26 and these have usually been excluded from such studies.
Fourth, individual studies use a wide range of outcome variables, and there is a lack of consensus on the reliability of the laboratory markers used. 27, 28 For example, serum albumin and prealbumin can be reduced during episodes of metabolic stress, such as sepsis. 29 There is also some debate regarding their use as markers of malnutrition status. 11, 27 Similarly, while there is adequate understanding of what constitutes "deficient" values for individual micronutrients, there is no clarity on "critical" thresholds per micronutrient in DFU, below which healing is unequivocally impaired.
Fifth, it is unclear what is the minimum duration required to achieve a measurable impact on the wound once the serum level of particular nutrient has improved beyond the deficient range. For example, Razzaghi et al 26 report that serum vitamin D was >25 ng/mL at the end of the study, but do not report the median duration to reach the threshold.
Sixth, ensuring compliance can be notoriously challenging. Most studies fail to report on this. One Swedish RCT on Fortimel supplementation reported that 25% of participants withdrew from the study, and there were challenges with the rest of the participants in ascertaining compliance. 16 Another study, in post-hip fracture patients, reported that less than half (<50%) took all their prescribed supplements. 30 Without meticulous data collection of this very important variable, it is difficult to ascribe any direct benefit to a particular nutritional intervention.
Seventh, there is a distinct lack of investigator led-clinical studies in this field. Although the contribution from industryled studies is robust, independent corroboration of their positive findings is important.
In conclusion, nutritional enhancement may have an important complementary role in DFU healing, as rightly pointed out by Kulprachakarn et al. 21 However, significant further work is required to ascertain which groups of The International Journal of Lower Extremity Wounds 16 (4) patients with DFU may benefit most from nutritional supplementation. In the meantime, priority must be given to early referral to a diabetes foot multidisciplinary team, prompt revascularization of ischemia, aggressive treatment of infection and appropriate offloading. [31] [32] [33] It is also important to remember that the origin of micronutrient deficiencies is inadequate diet, and the same holds true for protein energy malnutrition. Therefore, patients with DFU are likely to benefit from broad dietetic consultation. Indeed, this is perhaps why the American Diabetes Association does not specifically advocate nutritional supplementation in the management of diabetes or its complications. Instead, it supports healthful eating patterns and puts emphasis on nutrient-dense foods in appropriate portion sizes. 34, 35 Thus, in today's clinical reality, widespread nutritional supplementation in DFU patients can only be considered after results from rigorous trials with longer duration and clear reporting of concomitant medical care become available.
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr P. R. J. Vas has received speaker honoraria from Sanofi Diabetes and MSD. Prof M. E. Edmonds has been an advisory board member for Edixomed, Urgo Medical, Knox Technologies and Limflow. Dr N. Papanas has been an advisory board member of TrigoCare International; has participated in sponsored studies by Novo Nordisk and Novartis; has received honoraria as a speaker for Astra-Zeneca, Eli-Lilly, Novo Nordisk and Pfizer; and attended conferences sponsored by TrigoCare International, Novo Nordisk, Sanofi-Aventis, and Pfizer.
